<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Kiilerich Burnett | Activity</title>
	<link>https://www.catswannabecats.com/members/russialoaf16/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/russialoaf16/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Kiilerich Burnett.</description>
	<lastBuildDate>Mon, 29 Jun 2026 08:05:37 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">bcf8d70878005e07aa2b7cfc0a840a9b</guid>
				<title>Kiilerich Burnett posted an update: response and, hence could lead the way to find a potential [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23941/</link>
				<pubDate>Sun, 08 Jun 2025 10:58:02 -0400</pubDate>

									<content:encoded><![CDATA[<p>response and, hence could lead the way to find a potential marker for progression-free survival.</p>
<p> Care pathways are primarily aimed at decreasing length of hospital stay (LOS) and preventing unnecessary costs while maintaining or improving the quality of care. In laparoscopic cholecystectomy, there is insufficient evidence for proving an impact&hellip;<span class="activity-read-more" id="activity-read-more-23941"><a href="https://www.catswannabecats.com/activity/p/23941/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0993dfb9268c155ed31296d055f220f1</guid>
				<title>Kiilerich Burnett posted an update: Tumor lysis syndrome (TLS) and neutropenia are significant [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20811/</link>
				<pubDate>Fri, 06 Jun 2025 11:21:11 -0400</pubDate>

									<content:encoded><![CDATA[<p>Tumor lysis syndrome (TLS) and neutropenia are significant toxicities in the treatment of chronic lymphocytic leukemia (CLL). Both TLS and neutropenia can lead to potentially life-threatening complications for patients with chronic lymphocytic leukemia undergoing antineoplastic therapy. This article focuses on diligent risk assessment,&hellip;<span class="activity-read-more" id="activity-read-more-20811"><a href="https://www.catswannabecats.com/activity/p/20811/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4c096eb80557705f70c8b772048b5ef4</guid>
				<title>Kiilerich Burnett posted an update: This may be minimized by controlled experiments involving [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/10234/</link>
				<pubDate>Sun, 01 Jun 2025 00:05:54 -0400</pubDate>

									<content:encoded><![CDATA[<p>This may be minimized by controlled experiments involving the collection of testicular tissue and sperm from the same individuals, integrated in a clinically characterized cohort of healthy and infertile men. The analysis of specific subcellular proteomes can add more information to the proteomic puzzle, opening new treatment possibilities for&hellip;<span class="activity-read-more" id="activity-read-more-10234"><a href="https://www.catswannabecats.com/activity/p/10234/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dabc32440c24e849d0c34f778a773ab4</guid>
				<title>Kiilerich Burnett became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/7586/</link>
				<pubDate>Sat, 31 May 2025 19:36:04 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>